Published by Wanda Rich
Posted on April 23, 2025
The global automated external defibrillators market is expected to grow significantly. For the forecast period 2022-2032, a whopping CAGR of 11% is predicted, reaching US$ 48.26 billion. Technological advancements, as well as increased government involvement through research funding, will drive up demand for automated external defibrillators.
According to the World Journal of Cardiovascular Diseases, approximately 20% of the Western population suffers from cardiac problems. This is due to an increase in obesity, diabetes, smoking habits, high cholesterol, and sedentary lifestyles.
As a result, hospitals are increasingly looking for ways to resuscitate patients suffering from sudden cardiac arrests and ensure rapid response via defibrillators in order to avoid fatalities. Funding for research and development of novel medical technologies that address cardiac emergencies is increasing.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4640
Key Takeaways from the Market Study
"The global market for automated external defibrillators is expected to grow in the future. Increased government support in the form of research funding for cardiac issues will drive market growth. Key companies are focusing on developing new devices with cutting-edge technology to address heart-related issues," says a Fact.MR analyst.
Leading Players Driving Innovation in the Automated External Defibrillators Market
Koninklijke Philips; Physio-Control Inc. (Stryker); Nihon Koden Corporation; Asahi Kasei Medical Co. Ltd; GE Healthcare Ltd.
Country-wise Analysis
The United States will lead the global market for automated external defibrillators. The increasing incidence of sudden cardiac arrests is given as a key reason for the large market share. During the forecast period, the availability of automated external defibrillators is likely to increase market share. In addition, growing government intervention in promoting greater use of automated external defibrillators is likely to drive market growth. From 2022 to 2032, the CAGR is forecasted to be 8%.
China holds vast growth potential in the future. A growing population, as a result of which there will be a rise in cardiovascular diseases, is expected to propel market growth. In the forecasted period, an impressive growth of 7.7% is projected.
CompetitiveLandscape
With a highly consolidated market, the key players in automated external defibrillators are primarily focused on developing new products. Philips Healthcare, for example, manufactures the HearStart ranges of devices such as the FR3, OnSite, and FRx. Because of their sturdy construction and light weight, these devices are easy to use. Similarly, Stryker manufactures the HeartSine Samaritan PAD 350P, HeartSine Samaritan PAD 360P, LIFEPAK 100 Defibrillator, and LIFEPAK CR Plus devices. The PAD series includes a programme manager that alerts users to potential malfunctions that may impair device performance.
Get Customization on this Report for Specific Research Solutions-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4640
More Valuable Insights
Fact.MR, in its new report, offers an unbiased analysis of the global automated external defibrillators market, analyzing historical demand from 2015-2021 and forecast statistics for 2022–2032.
The study reveals growth projections on the automated external defibrillators market on the basis of key technologies (semi-automatic and fully-automatic), key sizes (standard automated external defibrillators and pediatric automated external defibrillators) and end users (hospitals, public access, emergency medical services, homes, work spaces and private cardiac clinics) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Check out More Related Studies Published by Fact.MR:
Trauma Care Centers Market is projected to grow from USD 16.2 billion in 2024 to USD 36.7 billion by 2035, at a CAGR of 7.7%.
Surgical Headlights Market will rise from US$ 1.9 billion in 2022 to US$ 2.4 billion by 2027, growing at a CAGR of 5%.
Hemostasis Diagnostics Market is expected to double from US$ 2 billion in 2020 to over US$ 4 billion by 2031, at a CAGR of 7%; point-of-care testing systems will grow at 5% CAGR.
Blood Cancer Diagnostics Market is forecast to grow from US$ 15.05 billion in 2021 to US$ 28.57 billion by 2032, registering a CAGR of 6%.
NGS Sample Preparation Market will expand from US$ 3.8 billion in 2021 to US$ 8.5 billion by 2032, with a CAGR of 7.3%.
Antibody Drug Conjugate Contract Market is expected to rise from US$ 9.2 billion in 2022 to US$ 38.8 billion by 2032, at a CAGR of 15.5%.
Manual Resuscitators Market is projected to grow from US$ 400 million to US$ 780 million between 2022 and 2032, at a CAGR of 7%.
Point of Care Diagnostics Market is set to grow from US$ 34.1 billion in 2020 to US$ 66 billion by 2028, with a CAGR of 7%.
Explore more articles in the Research Reports category
